Overview

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 2% solution in women with female pattern hair loss. All treatments will be provided in a double-blinded fashion except for minoxidil 2% solution which will be provided open-label.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Minoxidil
Pharmaceutical Solutions